title: NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine.
authors.affiliation: Institute of Internal Medicine, Infectious Diseases and Immunopathology, University of Milan, Italy.
authors.forename: M C
authors.initials: MC
authors.lastname: Honorati
authors.forename: P
authors.initials: P
authors.lastname: Travaglini
authors.forename: B
authors.initials: B
authors.lastname: De Bernardi
authors.forename: R
authors.initials: R
authors.lastname: Scorza
authors.forename: C
authors.initials: C
authors.lastname: Hu
authors.forename: M E
authors.initials: ME
authors.lastname: Togni
authors.forename: L
authors.initials: L
authors.lastname: Radelli
authors.forename: M
authors.initials: M
authors.lastname: Vanoli
authors.forename: C
authors.initials: C
authors.lastname: Zanussi
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011388:Prolactin / Q000097:blood*; D015175:Prolactinoma / Q000188:drug therapy / Q000276:immunology*; D012016:Reference Values
chemical_list: D001971:Bromocriptine; D011388:Prolactin